210 related articles for article (PubMed ID: 32643166)
1. Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: Results from UK primary care.
Mongkhon P; Alwafi H; Fanning L; Lau WCY; Wei L; Kongkaew C; Wong ICK
Br J Clin Pharmacol; 2021 Mar; 87(3):1056-1068. PubMed ID: 32643166
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with non-prescription of oral anticoagulant treatment in non-valvular atrial fibrillation patients with dementia: a CPRD-HES study.
Besford M; Graham S; Sammon C; Mehmud F; Allan V; Alikhan R; Ramagopalan S
Age Ageing; 2020 Jul; 49(4):679-682. PubMed ID: 32242616
[TBL] [Abstract][Full Text] [Related]
3. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.
Mitchell A; Snowball J; Welsh TJ; Watson MC; McGrogan A
BMC Med; 2021 Aug; 19(1):189. PubMed ID: 34461899
[TBL] [Abstract][Full Text] [Related]
4. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
J Interv Card Electrophysiol; 2023 Apr; 66(3):771-782. PubMed ID: 35804258
[TBL] [Abstract][Full Text] [Related]
6. Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation.
Deguchi I; Osada T; Arai N; Takahashi S
Heart Vessels; 2022 May; 37(5):867-874. PubMed ID: 34797401
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
Cadogan SL; Powell E; Wing K; Wong AY; Smeeth L; Warren-Gash C
Heart; 2021 Dec; 107(23):1898-1904. PubMed ID: 34645643
[TBL] [Abstract][Full Text] [Related]
9. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation.
Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM
Eur J Clin Invest; 2021 May; 51(5):e13457. PubMed ID: 33222261
[TBL] [Abstract][Full Text] [Related]
12. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
13. Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Garrahy E; Bindoff I; Peterson GM
J Am Heart Assoc; 2022 Apr; 11(7):e023098. PubMed ID: 35301852
[TBL] [Abstract][Full Text] [Related]
14. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
[TBL] [Abstract][Full Text] [Related]
15. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
16. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with oral anticoagulant prescription status among patients with a new diagnosis of atrial fibrillation.
Manning E; Burns K; Laurie M; Patten L; Ho M; Sandhu A
Clin Cardiol; 2023 Aug; 46(8):937-941. PubMed ID: 37401357
[TBL] [Abstract][Full Text] [Related]
18. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
19. Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019.
Gorczyca-Głowacka I; Bielecka B; Wałek P; Chrapek M; Ciba-Stemplewska A; Jelonek O; Kot A; Czyżyk A; Pióro M; Major A; Wożakowska-Kapłon B
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35564979
[TBL] [Abstract][Full Text] [Related]
20. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
